What is HC Wainwright’s Estimate for INKT Q1 Earnings?
MiNK Therapeutics, Inc. (NASDAQ:INKT – Free Report) – Analysts at HC Wainwright issued their Q1 2025 EPS estimates for shares of MiNK Therapeutics in a research report issued to clients and investors on Tuesday, February 25th. HC Wainwright analyst E. Bodnar forecasts that the company will post earnings of ($0.51) per share for the quarter. […]
